317 related articles for article (PubMed ID: 23981095)
1. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease.
Ng SC; Lam YT; Tsoi KK; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2013 Oct; 38(8):854-63. PubMed ID: 23981095
[TBL] [Abstract][Full Text] [Related]
2. Herbal and plant therapy in patients with inflammatory bowel disease.
Triantafyllidi A; Xanthos T; Papalois A; Triantafillidis JK
Ann Gastroenterol; 2015; 28(2):210-220. PubMed ID: 25830661
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.
Langhorst J; Wulfert H; Lauche R; Klose P; Cramer H; Dobos GJ; Korzenik J
J Crohns Colitis; 2015 Jan; 9(1):86-106. PubMed ID: 25518050
[TBL] [Abstract][Full Text] [Related]
4. Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.
Rahman H; Kim M; Leung G; Green JA; Katz S
Curr Treat Options Gastroenterol; 2017 Dec; 15(4):618-636. PubMed ID: 28918484
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
10. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Inflamm Bowel Dis; 2020 Mar; 26(4):502-509. PubMed ID: 31613959
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W
Inflamm Bowel Dis; 2011 Feb; 17(2):573-82. PubMed ID: 20848527
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease.
Yang C; Singh P; Singh H; Le ML; El-Matary W
Aliment Pharmacol Ther; 2015 Jun; 41(11):1079-93. PubMed ID: 25858208
[TBL] [Abstract][Full Text] [Related]
13. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
[TBL] [Abstract][Full Text] [Related]
14. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.
Shen J; Zuo ZX; Mao AP
Inflamm Bowel Dis; 2014 Jan; 20(1):21-35. PubMed ID: 24280877
[TBL] [Abstract][Full Text] [Related]
15. Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies.
Bahnam P; Hanzel J; Ma C; Zou L; Narula N; Singh S; Kahan B; Jairath V
J Crohns Colitis; 2023 Apr; 17(3):404-417. PubMed ID: 36219564
[TBL] [Abstract][Full Text] [Related]
16. Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.
Farkas K; Rutka M; Ferenci T; Nagy F; Bálint A; Bor R; Milassin Á; Fábián A; Szántó K; Végh Z; Kürti Z; Lakatos PL; Szepes Z; Molnár T
Expert Opin Biol Ther; 2017 Nov; 17(11):1325-1332. PubMed ID: 28819991
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
Cholapranee A; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
[TBL] [Abstract][Full Text] [Related]
18. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.
Colombel JF; Jharap B; Sandborn WJ; Feagan B; Peyrin-Biroulet L; Eichner SF; Robinson AM; Mostafa NM; Zhou Q; Thakkar RB
Aliment Pharmacol Ther; 2017 Jan; 45(1):50-62. PubMed ID: 27883215
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
20. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
